• Journal of Society of Preventive Korean Medicine
• /
• v.20 no.2
• /
• pp.69-75
• /
• 2016

Objectives : The aim of this study is to introduce the Korean medicine respiratory management program in public health center and to analyze the effects of that program. Methods : The respiratory management program was targeted on 22 soldiers during March 2016. The interventions of this program were herbal medicines (Gilgyung-tang and so on), aromatherapy, peppermint tea, fine dust mask, and health education. Data were collected by retrospective reviewing medical chart and analyzed using SPSS 18.0. Results : Total symptoms scores were measured by 4-point likert scale. Total score was $5.50{\pm}4.848$ at 1st week and $3.27{\pm}3.058$ at 4th week (p=0.008). The severity of respiratory discomfort reduced by $-1.14{\pm}2.46$ compared with last year. The satisfaction score was $7.82{\pm}4.16$. The most hoping program was muscular skeletal disease management program. Conclusions : This study suggests that Korean medical world should prepare countermeasures to cope with diseases caused by air pollution.

• Tuberculosis and Respiratory Diseases
• /
• v.86 no.4
• /
• pp.264-271
• /
• 2023

Chronic cough is a common problem that can be refractory to medical treatment. Nonpharmaceutical management of chronic cough has an important role in well selected patients. This review article outlines the history of chronic cough management, current approaches to speech pathology management of the condition and new modalities of nonpharmaceutical treatment. There is a need for further research into nonpharmaceutical options with well described randomised control trials.

• Tuberculosis and Respiratory Diseases
• /
• v.62 no.2
• /
• pp.95-97
• /
• 2007

• Journal of Digital Convergence
• /
• v.15 no.10
• /
• pp.315-326
• /
• 2017

This purpose of this study was to identify factors influencing performance about practice of infections management by child care center teachers about respiratory tract infection. The participant were 432 teachers working in child care center. Data were collected from July 2 to August 20, 2015 through a self-report questionnaire survey. The data was analyzed using the SPSS/WIN 18.0 program with descriptive analysis, t-test, one-way ANOVA, Pearson's correlation coefficient and Stepwise multiple regression analysis. Knowledge about causes and symptom of respiratory tract infections(${\beta}=.096$, p<.001),parenting experience(${\beta}=-1.993$, p<.001), and nursing knowledge(${\beta}=-.371$, p<.001) had significant positive effects on the practice of infection management. Explained variance for the practice of infection management was 43.4% and nursing knowledge was the most significant factor in the practice of infection management of child care center teachers.

• Journal of Acupuncture Research
• /
• v.31 no.3
• /
• pp.67-73
• /
• 2014

Objectives : Amyotrophic lateral sclerosis(ALS) is a progressive neurodegenerative disorder characterized by a selective death of motor neuron, leading to respiratory insufficiency. The purpose of this study was to assess the long term respiratory management of ALS patient with respiratory failure. Methods : One ALS patient applying a non-invasive BIPAP ventilator as well as Korean medical treatment such as acupuncture, pharmacopuncture and herbal medicine was measured on $SpO_2$, $EtCO_2$, Vte(expiratorytidalvolume) for 2 years 7 months. Results : The $SpO_2$, $EtCO_2$ of ALS patient were maintained in the normal range for 2 years 7 months. The Vte of ALS patient also wasn't worse in this study. Conclusions : In this study, the long term respiration management, combined administration of Korean medical treatment and non-invasive BIPAP ventilator, could be effective in ALS patient with respiratory failure.

• Journal of the Korea Society of Computer and Information
• /
• v.26 no.11
• /
• pp.21-31
• /
• 2021

As the COVID-19 pandemic rapidly changes healthcare around the globe, the need for smart healthcare that allows for remote diagnosis is increasing. The current classification of respiratory diseases cost high and requires a face-to-face visit with a skilled medical professional, thus the pandemic significantly hinders monitoring and early diagnosis. Therefore, the ability to accurately classify and diagnose respiratory sound using deep learning-based AI models is essential to modern medicine as a remote alternative to the current stethoscope. In this study, we propose a deep learning-based respiratory sound classification model using data collected from medical experts. The sound data were preprocessed with BandPassFilter, and the relevant respiratory audio features were extracted with Log-Mel Spectrogram and Mel Frequency Cepstral Coefficient (MFCC). Subsequently, a Parallel CNN network model was trained on these two inputs using stacking ensemble techniques combined with various machine learning classifiers to efficiently classify and detect abnormal respiratory sounds with high accuracy. The model proposed in this paper classified abnormal respiratory sounds with an accuracy of 96.9%, which is approximately 6.1% higher than the classification accuracy of baseline model.

• Tuberculosis and Respiratory Diseases
• /
• v.85 no.4
• /
• pp.320-331
• /
• 2022

Coronavirus disease 2019 (COVID-19) has become a major health burden worldwide, with over 450 million confirmed cases and 6 million deaths. Although the acute phase of COVID-19 management has been established, there is still a long way to go to evaluate the long-term clinical course or manage complications due to the relatively short outbreak of the virus. Pulmonary fibrosis is one of the most common respiratory complications associated with COVID-19. Scarring throughout the lungs after viral or bacterial pulmonary infection have been commonly observed, but the prevalence of post-COVID-19 pulmonary fibrosis is rapidly increasing. However, there is limited information available about post-COVID-19 pulmonary fibrosis, and there is also a lack of consensus on what condition should be defined as post-COVID-19 pulmonary fibrosis. During a relatively short follow-up period of approximately 1 year, lesions considered related to pulmonary fibrosis often showed gradual improvement; therefore, it is questionable at what time point fibrosis should be evaluated. In this review, we investigated the epidemiology, risk factors, pathogenesis, and management of post-COVID-19 pulmonary fibrosis.

• Tuberculosis and Respiratory Diseases
• /
• v.83 no.2
• /
• pp.116-121
• /
• 2020

Particulate matter (PM) is suspended dust that has a diameter of <10 ㎛ and can be inhaled by humans and deposited in the lungs, particularly the alveoli. Recent studies have shown that PM has an adverse effect on respiratory diseases. The aim of this article is to review respiratory diseases associated with PM. According to existing studies, PM is associated with chronic obstructive pulmonary disease, bronchial asthma, and several other respiratory diseases and increases the mortality rates of these diseases. Moreover, increased exposure in the high concentration of atmospheric PM is associated with the development of lung cancer. The most simple and common way to protect an individual from airborne PM is to wear a face mask that filters out PM. In areas of high concentration PM, it is recommended to wear a face mask to minimize the exposure to PM. However, the use of N95 or KF94 masks can interfere with respiration in patients with chronic respiratory diseases who exhibit low pulmonary function, leading to an increased risk of respiratory failure. Conclusionally, reduction of the total amount of PM is considered to be important factor and strengthening the national warning notification system to vulnerable patients and proper early management of exacerbated patients will be needed in the future.

• Tuberculosis and Respiratory Diseases
• /
• v.84 no.1
• /
• pp.22-34
• /
• 2021

The coronavirus pandemic, known as coronavirus disease 2019 (COVID-19), is an infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus first identified in patients from Wuhan, China. Since December 2019, SARS-CoV-2 has spread swiftly around the world, infected more than 25 million people, and caused more than 800,000 deaths in 188 countries. Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) appear to be risk factors for COVID-19, however, their prevalence remains controversial. In fact, studies in China reported lower rates of chronic respiratory conditions in patients with COVID-19 than in the general population, while the trend is reversed in the United States and Europe. Although the underlying molecular mechanisms of a possible interaction between COVID-19 and chronic respiratory diseases remain unknown, some observations can help to elucidate them. Indeed, physiological changes, immune response, or medications used against SARS-CoV-2 may have a greater impact on patients with chronic respiratory conditions already debilitated by chronic inflammation, dyspnea, and the use of immunosuppressant drugs like corticosteroids. In this review, we discuss importance and the impact of COVID-19 on asthma and COPD patients, the possible available treatments, and patient management during the pandemic.

• The Journal of Internal Korean Medicine
• /
• v.39 no.3
• /
• pp.443-449
• /
• 2018

Objective: This case reports the management of a patient with bronchiectasis treated with Sikyungbanha-tang, an herbal extract covered by national health insurance. Methods: Twice a year, the patient was treated for a 30-day period with the herbal extract Sikyungbanha-tang. History-taking and a chest X-ray (CXR) were used to evaluate the effects. Results: Following treatment with herbal medicine, the patient's complaints of symptoms decreased, and improvement was shown on CXR. Conclusions: Sikyungbanha-tang in herbal extract form in insured herbal extracts has effects on the management of bronchiectasis patients.